Prof. Dr. Abhijit Saha: Professor at The Neotia University, India
Dr. Abhijit Saha, PhD, is a highly motivated and detail-oriented Research Scholar and Professor with extensive expertise in pharmaceutical chemistry, molecular biology, and drug design. Over the past 15 years, he has focused on synthesizing novel anticancer compounds and applying advanced analytical and biological techniques to evaluate their efficacy. His research integrates synthetic organic chemistry with computational drug design and in vitro/in vivo studies, aiming to develop effective therapeutics for multiple cancer types. Passionate about mentoring, he actively guides students and contributes to multidisciplinary research addressing real-world biomedical challenges.
Online Profile
Dr. Abhijit Saha’s research contributions have garnered a total of 11 citations across his publications, with 9 citations coming from his recent impactful works. His scholarly influence is also reflected in an h-index of 2, demonstrating the recognition of his research within the scientific community and his growing presence in the fields of pharmaceutical chemistry and drug design.
Education
Dr. Saha earned his Ph.D. in Pharmaceutical Chemistry from Biju Patnaik University of Technology, Odisha, completing his doctoral research between 2015 and 2023. His thesis focused on the design, synthesis, and biological evaluation of novel anticancer molecules targeting multiple myeloma and other cancer strains. Prior to his Ph.D., he completed his M.Pharm in Pharmaceutical Chemistry at the same university with a strong academic record, followed by a B.Pharm degree from Berhampur University, Odisha, where he graduated with first-class honors.
Research Focus
His research is centered on the development of new anticancer drug candidates through synthetic organic and medicinal chemistry. He specializes in pharmacophore-based drug design and molecular docking studies targeting cancer-related receptors, and method development and validation of pharmaceutical compounds using RP-HPLC, UV, and IR spectroscopy. He is experienced in the biological evaluation of compounds on various cancer cell lines including Sarcoma-180, Ehrlich Ascites Carcinoma, Multiple Myeloma, NSCLC, and Breast cancer. Additionally, he extracts and screens phytochemicals for their antimicrobial and anticancer properties, contributing to natural product research and drug discovery.
Experience
Dr. Saha currently serves as a Professor at The Neotia University, where he delivers lectures in pharmaceutical chemistry and analysis, guides M.Pharm dissertation projects, and provides consultancy services in HPLC, UV spectroscopy, and drug designing. Prior to this, he was a Professor and Associate Professor at the College of Pharmaceutical Sciences in Berhampur, Odisha, where he taught undergraduate and postgraduate courses in pharmaceutical and organic chemistry while supervising numerous research projects. He began his academic career as an Assistant Professor and Lecturer at the same institution, where he gained extensive experience in teaching and mentoring students.
Research Timeline & Activities
In 2025, Dr. Saha coordinated a comprehensive three-day hands-on workshop focused on HPLC and UV spectrophotometry, aimed at enhancing practical skills among researchers and students. From 2015 to 2023, his Ph.D. research involved the design, synthesis, and biological evaluation of novel anticancer agents, with a particular emphasis on apoptosis enhancement and antiangiogenic activity. He has conducted numerous molecular docking and pharmacophore modeling studies to develop multi-target tyrosine kinase inhibitors and has extracted bioactive compounds from medicinal plants to evaluate their anticancer and antimicrobial potential. Additionally, he has developed and validated analytical methods for drug stability and degradation studies using RP-HPLC and UV techniques, contributing to quality control in pharmaceuticals.
Awards & Honors
Dr. Saha’s academic excellence is reflected in his performance on the Graduate Aptitude Test in Engineering (GATE), where he secured an All India Rank of 2420 in 2006 and an 82.97 percentile in 2008. He was awarded a UGC Minor Research Project focusing on the synthesis and biological evaluation of novel glutamic acid analogs with antitumor and antiangiogenic properties. His contributions also include coordinating workshops and successfully mentoring numerous postgraduate research students, highlighting his commitment to academic leadership and professional development.
Top Noted Publication
Among Dr. Saha’s many publications, one of his most notable works is the article titled “Analogue-Based Design, Synthesis, and Antimicrobial Study of Aryl and Heteroaryl Sulfonamides as Multi-Targeted Antimicrobial Compounds,” published in the Russian Journal of Bioorganic Chemistry in 2025. This research presents innovative synthetic strategies and comprehensive biological evaluation of sulfonamide derivatives as potent antimicrobial agents, underscoring his interdisciplinary expertise in drug discovery and design.
A Validated Stability Indicating RP-HPLC Method for Estimation of Avapritinib in Bulk and Tablet Dosage Form
Subrata Sen, Koushik Sarker, Avijit Ghosh, Suvasish Mishra, Abhijit Saha
International Journal of Applied Pharmaceutics, 14(2), 95-101, 2021
Citations: 5Possible Antineoplastic Agents, Part XVI: Synthesis, in vivo Antitumor and in vitro Antiangiogenic Study of Few Glutamic Acid Analogs
S. Sen, K. Sarker, A. Ghosh, S. Mishra, A. Saha, D. Goswami, T. Jha, J.K. Gupta
International Journal of Pharmaceutical Sciences and Research, 10(2), 118-124, 2011
Citations: 4Analogue Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Some Thalidomide Metabolites as Selective Cytotoxic and Antiangiogenic Agents Against Multiple Myeloma
A. Saha, K. Sarker, A. Ghosh, S. Mishra, S. Sen
Russian Journal of Bioorganic Chemistry, 48(1), 115-124, 2022
Citations: 1Identification, Biological Evaluation & Retrometabolic Drug Designing of Active Metabolites of 5-Amino-4-(3,4-Dimethoxy Phenyl Sulfonamido)-5-Oxopentanoic Acid (SM-1) As Antimultiple Myeloma and Antiangiogenic Agents
S.S. Abhijit Saha, Koushik Sarker, Avijit Ghosh, Suvasish Mishra
Annals of the Romanian Society for Cell Biology, 25(5), 458-469, 2021
Citations: 1Bioinformatics Approaches for the Validation of Functional Analysis of 3D Cancer Models
Tripti Sharma, Ipsa Padhy, Abhijit Saha (co-author)
In 3D Bioprinting in Cancer Applications, Academic Press, 2025, pp. 85-110
Strengths for the Healthcare Innovation Award
Innovative Anticancer Drug Design and Synthesis
Dr. Abhijit Saha has demonstrated exceptional expertise in the design and synthesis of novel anticancer molecules by integrating traditional synthetic organic chemistry with modern computational techniques such as molecular docking and pharmacophore modeling. His work targets multiple cancer types by developing multi-targeted inhibitors, which enhances therapeutic efficacy while potentially reducing side effects. This innovative approach contributes significantly to advancing personalized and precision medicine in oncology.
Advanced Analytical Method Development and Validation
He has developed and rigorously validated robust stability-indicating analytical methods, including RP-HPLC and UV spectrophotometry, essential for the accurate quantification of pharmaceutical compounds in bulk drugs and dosage forms. These analytical advancements ensure high standards in drug quality control, stability assessment, and regulatory compliance, thereby supporting the safe and effective delivery of medications to patients.
Interdisciplinary and Translational Research Focus
Dr. Saha’s research uniquely combines synthetic chemistry, computational biology, and experimental pharmacology to bridge the gap between laboratory research and clinical application. His translational focus on anticancer and antimicrobial drug development facilitates the transformation of basic scientific discoveries into viable therapeutic agents, addressing critical healthcare challenges and improving patient outcomes.
Leadership in Capacity Building and Academic Mentorship
Beyond his research contributions, Dr. Saha is committed to fostering scientific talent and innovation through the organization of hands-on workshops on HPLC, UV spectroscopy, and drug design techniques. His active mentorship of graduate and postgraduate students encourages the development of practical skills and innovative thinking, preparing a skilled workforce equipped to tackle future healthcare problems.
Significant Scholarly Impact and Collaborative Innovation
With numerous peer-reviewed publications and consistent citation records, Dr. Saha’s work has been recognized internationally for its scientific rigor and innovation. His collaborative efforts with fellow researchers in medicinal chemistry and bioinformatics have led to multidisciplinary projects that enhance the discovery and development of novel therapeutic agents, reinforcing his role as a leader in healthcare innovation.